|

Multi-epitope HER2 Peptide Vaccine H2NVAC Clinical Trials

1 actively recruiting trial across 1 location

Also known as: H2NVAC, HER2 Peptide Vaccine H2NVAC, HER2 Specific Helper T-cell Epitope Vaccine H2NVAC

Pipeline

Phase 1: 1

Top Sponsors

  • Mayo Clinic1

Indications

  • Breast Ductal Carcinoma In Situ1
  • Breast Cancer1
  • Cancer1

Jacksonville, Florida1 trial

A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

Mayo Clinic in Florida

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.